HIV in-Site Knowledge Base

New or updated chapters from May and June include:

• Antiretroviral treatment monitoring in developing countries: related resources
  http://hivinsite.ucsf.edu/InSite?page=kbr-03-01-19
• Dosage adjustments for ARV-ARV drug interactions (adult dosing)
  http://hivinsite.ucsf.edu/InSite?page=md-rr-24
• Dosing for ritonavir-boosted protease inhibitors: a table of dosage adjustments for treatment regimens including ritonavir-boosted protease inhibitors
  http://hivinsite.ucsf.edu/InSite?page=md-rr-23
• Warning of interactions between trazodone and 3A4 inducers/inhibitors.
  http://hivinsite.ucsf.edu/InSite?page=ar-alert

Hopkins report – May 2004

http://hopkins-aids.edu/publications/report/report_toc_04.html

• Genes, ethnicity, and efavirenz response: clinical pharmacology update from the 11th CROI
• HIV superinfection: can patients be infected twice?
• Syphilis rates climb again
• Travel advice for HIV-infected individuals

Medscape

(Requires one-time free registration)

Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmocokinetics and avoidance of drug resistance

http://www.medscape.com/viewarticle/477466

Identification and management of neurologic and psychiatric side effects associated with HIV and HAART

http://www.medscape.com/viewprogram/2960

PRN Notebook – June 2003

http://www.prn.org/prn_nb_cntnt/current.htm

• Pharmacokinetics, pharmacogenetics, and HIV
• Update on the treatment of acute and early HIV
• HIV and cardiovascular disease: responding to the risk
• Diagnosis and management of HPV-associated anogenital dysplasia in HIV-infected men and women
• Antiretrovirals for the World: needs and challenges